Recent research trial demonstrate that the radiation therapy drug AZEDRA (ultratrace iobenguane I 131) is an effective and safe treatment option for patients that have rare neuroendocrine cancer tumors such as pheochromocytoma and paraganglioma. AZEDRA is designed for patients that have run out of other options and are facing recurring, malignant, or unresectable cases of these cancers. Pheochromocytoma is a neuroendocrine tumor that originates in chromaffin cells, which are found in the medulla of the adrenal gland.
It can be benign or cancerous. The cause is typically genetic, and is found to be inherited in around a quarter of cases. Symptoms include High blood pressure and heart rate Flank pain Headaches Heavy sweating Palpitations Anxiety Weight loss Abnormal skin sensations Pale skin Paraganglioma is closely related to pheochromocytoma, but it can originate at different areas,…
